Zifi 50 Dry Syrup contains Cefixime 50mg/5ml, a third-generation cephalosporin antibiotic effective against a broad spectrum of bacterial infections. It is primarily indicated for the treatment of respiratory tract infections, urinary tract infections, otitis media, pharyngitis, and uncomplicated gonorrhea caused by susceptible strains of bacteria. Cefixime works by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. The dry syrup formulation is particularly suitable for pediatric patients and those who have difficulty swallowing tablets. Prior to administration, the dry syrup should be reconstituted with the specified amount of water to ensure accurate dosing. Zifi 50 Dry Syrup should be used as directed by a healthcare professional, with dosage adjusted according to the severity of infection, patient age, and renal function. Common side effects may include gastrointestinal disturbances such as diarrhea, nausea, and abdominal pain. Hypersensitivity reactions, although rare, require immediate medical attention. It is contraindicated in patients with known hypersensitivity to cephalosporins or penicillins. Caution is advised in patients with a history of gastrointestinal disease, particularly colitis. Proper adherence to the prescribed course is essential to prevent the development of antibiotic resistance.